{"id":"https://openalex.org/W2936802406","doi":"https://doi.org/10.1073/pnas.1820175116","title":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","display_name":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","publication_year":2019,"publication_date":"2019-04-08","ids":{"openalex":"https://openalex.org/W2936802406","doi":"https://doi.org/10.1073/pnas.1820175116","mag":"2936802406","pmid":"https://pubmed.ncbi.nlm.nih.gov/30962368","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6511062"},"language":"en","primary_location":{"id":"doi:10.1073/pnas.1820175116","doi":"https://doi.org/10.1073/pnas.1820175116","is_oa":true,"landing_page_url":"https://doi.org/10.1073/pnas.1820175116","pdf_url":"https://www.pnas.org/content/pnas/116/19/9318.full.pdf","source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.pnas.org/content/pnas/116/19/9318.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038964748","display_name":"Susan Wyllie","orcid":"https://orcid.org/0000-0001-8810-5605","observed_orcids":["https://orcid.org/0000-0001-8810-5605"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Susan Wyllie","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003817946","display_name":"Stephen Brand","orcid":"https://orcid.org/0000-0002-7010-5348","observed_orcids":["https://orcid.org/0000-0002-7010-5348"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Brand","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081458584","display_name":"Michael G. Thomas","orcid":"https://orcid.org/0000-0003-0377-0281","observed_orcids":["https://orcid.org/0000-0003-0377-0281"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Thomas","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073950963","display_name":"Manu De Rycker","orcid":"https://orcid.org/0000-0002-3171-3519","observed_orcids":["https://orcid.org/0000-0002-3171-3519"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Manu De Rycker","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":"https://orcid.org/0000-0002-3171-3519","affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059463978","display_name":"Chun\u2010wa Chung","orcid":"https://orcid.org/0000-0002-2480-3110","observed_orcids":["https://orcid.org/0000-0002-2480-3110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chun-wa Chung","raw_affiliation_strings":["Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103544688","display_name":"Imanol Pe\u00f1a","orcid":"https://orcid.org/0000-0001-9518-8576","observed_orcids":["https://orcid.org/0000-0001-9518-8576"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Imanol Pena","raw_affiliation_strings":["Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073182160","display_name":"Ryan P. Bingham","orcid":"https://orcid.org/0000-0001-7990-224X","observed_orcids":["https://orcid.org/0000-0001-7990-224X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan P. Bingham","raw_affiliation_strings":["Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015594530","display_name":"Juan A. Bueren\u2010Calabuig","orcid":"https://orcid.org/0000-0003-3665-9002","observed_orcids":["https://orcid.org/0000-0003-3665-9002"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Juan A. Bueren-Calabuig","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023152671","display_name":"Juan Cantizani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Cantizani","raw_affiliation_strings":["Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043187017","display_name":"David\u00a0\u00c1lvaro Cebri\u00e1n","orcid":"https://orcid.org/0009-0006-5793-4172","observed_orcids":["https://orcid.org/0009-0006-5793-4172"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"David Cebrian","raw_affiliation_strings":["Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020875571","display_name":"Peter D. Craggs","orcid":"https://orcid.org/0000-0002-9546-6617","observed_orcids":["https://orcid.org/0000-0002-9546-6617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter D. Craggs","raw_affiliation_strings":["Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047663307","display_name":"Liam Ferguson","orcid":"https://orcid.org/0000-0002-1033-4181","observed_orcids":["https://orcid.org/0000-0002-1033-4181"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Liam Ferguson","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004580771","display_name":"Panchali Goswami","orcid":"https://orcid.org/0000-0002-8056-5946","observed_orcids":["https://orcid.org/0000-0002-8056-5946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Panchali Goswami","raw_affiliation_strings":["Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074065870","display_name":"Judith Varady Hobrath","orcid":"https://orcid.org/0000-0002-5399-5625","observed_orcids":["https://orcid.org/0000-0002-5399-5625"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Judith Hobrath","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038573409","display_name":"Jonathan Howe","orcid":"https://orcid.org/0009-0004-5204-3544","observed_orcids":["https://orcid.org/0009-0004-5204-3544"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Howe","raw_affiliation_strings":["David Jack Centre for R&D, GlaxoSmithKline, Ware SG12 0DP, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Jack Centre for R&D, GlaxoSmithKline, Ware SG12 0DP, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046661628","display_name":"Laura Jeacock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura Jeacock","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101809715","display_name":"Eun Jung Ko","orcid":"https://orcid.org/0000-0003-1222-1938","observed_orcids":["https://orcid.org/0000-0003-1222-1938"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Eun-Jung Ko","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Justyna Korczynska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justyna Korczynska","raw_affiliation_strings":["Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056236490","display_name":"Lorna M. MacLean","orcid":"https://orcid.org/0000-0002-5691-5117","observed_orcids":["https://orcid.org/0000-0002-5691-5117"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lorna MacLean","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013269649","display_name":"Sujatha Manthri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sujatha Manthri","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056397559","display_name":"Maria Santos Mart\u00ednez","orcid":"https://orcid.org/0000-0001-7894-2135","observed_orcids":["https://orcid.org/0000-0001-7894-2135"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria S. Martinez","raw_affiliation_strings":["Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021744354","display_name":"Lydia Mata-Cantero","orcid":"https://orcid.org/0000-0002-1924-3614","observed_orcids":["https://orcid.org/0000-0002-1924-3614"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lydia Mata-Cantero","raw_affiliation_strings":["Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027350167","display_name":"S\u00f3nia Moniz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sonia Moniz","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047590633","display_name":"Andrea N\u00fchs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrea N\u00fchs","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040010661","display_name":"Maria Osuna\u2010Cabello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maria Osuna-Cabello","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075267747","display_name":"\u00c9rika G. Pinto","orcid":"https://orcid.org/0000-0001-8036-2690","observed_orcids":["https://orcid.org/0000-0001-8036-2690"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Erika Pinto","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068550057","display_name":"Jennifer Riley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jennifer Riley","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106500256","display_name":"Sharon Robinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sharon Robinson","raw_affiliation_strings":["David Jack Centre for R&D, GlaxoSmithKline, Ware SG12 0DP, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Jack Centre for R&D, GlaxoSmithKline, Ware SG12 0DP, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089105481","display_name":"Paul Rowland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Rowland","raw_affiliation_strings":["Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046247183","display_name":"Frederick R. C. Simeons","orcid":"https://orcid.org/0009-0001-4987-1742","observed_orcids":["https://orcid.org/0009-0001-4987-1742"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Frederick R. C. Simeons","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060479849","display_name":"Yoko Shishikura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yoko Shishikura","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074239015","display_name":"Daniel Spinks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daniel Spinks","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080447691","display_name":"Laste Stojanovski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laste Stojanovski","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102728684","display_name":"John Charles Thomas","orcid":"https://orcid.org/0000-0002-4135-5604","observed_orcids":["https://orcid.org/0000-0002-4135-5604"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Thomas","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101824471","display_name":"Stephen Thompson","orcid":"https://orcid.org/0000-0003-1545-4729","observed_orcids":["https://orcid.org/0000-0003-1545-4729"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Thompson","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030445710","display_name":"Elisabet Viayna","orcid":"https://orcid.org/0000-0003-3253-0148","observed_orcids":["https://orcid.org/0000-0003-3253-0148"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elisabet Viayna Gaza","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019688477","display_name":"Richard J. Wall","orcid":"https://orcid.org/0000-0003-3487-3187","observed_orcids":["https://orcid.org/0000-0003-3487-3187"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard J. Wall","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052888003","display_name":"Fabio Zuccotto","orcid":"https://orcid.org/0000-0002-3888-7423","observed_orcids":["https://orcid.org/0000-0002-3888-7423"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Fabio Zuccotto","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006899799","display_name":"David Horn","orcid":"https://orcid.org/0000-0001-5173-9284","observed_orcids":["https://orcid.org/0000-0001-5173-9284"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Horn","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":"https://orcid.org/0000-0001-5173-9284","affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013454330","display_name":"Michael A. J. Ferguson","orcid":"https://orcid.org/0000-0003-1321-8714","observed_orcids":["https://orcid.org/0000-0003-1321-8714"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael A. J. Ferguson","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038753195","display_name":"Alan H. Fairlamb","orcid":"https://orcid.org/0000-0001-5134-0329","observed_orcids":["https://orcid.org/0000-0001-5134-0329"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan H. Fairlamb","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":"https://orcid.org/0000-0001-5134-0329","affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036858042","display_name":"Jos\u00e9 M. Fiandor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose M. Fiandor","raw_affiliation_strings":["Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053988731","display_name":"Julio J. Martin","orcid":"https://orcid.org/0000-0003-1887-0859","observed_orcids":["https://orcid.org/0000-0003-1887-0859"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Julio Martin","raw_affiliation_strings":["Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000615607","display_name":"David W. Gray","orcid":"https://orcid.org/0000-0001-9512-3828","observed_orcids":["https://orcid.org/0000-0001-9512-3828"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David W. Gray","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089962351","display_name":"Timothy J. Miles","orcid":"https://orcid.org/0000-0001-7407-7404","observed_orcids":["https://orcid.org/0000-0001-7407-7404"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Timothy J. Miles","raw_affiliation_strings":["Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033358436","display_name":"Ian Hugh Gilbert","orcid":"https://orcid.org/0000-0002-5238-1314","observed_orcids":["https://orcid.org/0000-0002-5238-1314"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ian H. Gilbert","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":"https://orcid.org/0000-0002-5238-1314","affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038804385","display_name":"Kevin D. Read","orcid":"https://orcid.org/0000-0002-8536-0130","observed_orcids":["https://orcid.org/0000-0002-8536-0130"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Kevin D. Read","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030325413","display_name":"Mar\u00eda Marco","orcid":"https://orcid.org/0000-0002-2442-0021","observed_orcids":["https://orcid.org/0000-0002-2442-0021"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Maria Marco","raw_affiliation_strings":["Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;"],"raw_orcid":"https://orcid.org/0000-0002-2442-0021","affiliations":[{"raw_affiliation_string":"Global Health R&D, GlaxoSmithKline, Tres Cantos, 28760, Spain;","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017389980","display_name":"Paul Graham Wyatt","orcid":"https://orcid.org/0000-0002-0397-245X","observed_orcids":["https://orcid.org/0000-0002-0397-245X"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I4210126499","display_name":"Wellcome Centre for Anti-Infectives Research","ror":"https://ror.org/02e6k9z27","country_code":"GB","type":"facility","lineage":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Paul G. Wyatt","raw_affiliation_strings":["Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5017389980","https://openalex.org/A5030325413","https://openalex.org/A5038804385"],"corresponding_institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210126499","https://openalex.org/I4210151147"],"apc_list":null,"apc_paid":{"value":4637,"currency":"EUR","value_usd":5001},"fwci":19.718,"has_fulltext":true,"cited_by_count":176,"citation_normalized_percentile":{"value":0.99701363,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"116","issue":"19","first_page":"9318","last_page":"9323"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10890","display_name":"Trypanosoma species research and implications","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12107","display_name":"Leprosy Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/visceral-leishmaniasis","display_name":"visceral leishmaniasis","score":1.0},{"id":"https://openalex.org/keywords/leishmania-donovani","display_name":"Leishmania donovani","score":0.9179999828338623},{"id":"https://openalex.org/keywords/leishmania-infantum","display_name":"Leishmania infantum","score":0.9990000128746033},{"id":"https://openalex.org/keywords/proteasome-inhibition","display_name":"proteasome inhibition","score":0.9449999928474426},{"id":"https://openalex.org/keywords/beta5-subunit","display_name":"beta5 subunit","score":0.7649999856948853},{"id":"https://openalex.org/keywords/chymotrypsin-like-activity","display_name":"chymotrypsin-like activity","score":0.9409999847412109},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.8169999718666077},{"id":"https://openalex.org/keywords/trypanosoma-cruzi","display_name":"Trypanosoma cruzi","score":0.9210000038146973},{"id":"https://openalex.org/keywords/20s-proteasome","display_name":"20S proteasome","score":0.8100000023841858},{"id":"https://openalex.org/keywords/inhibitor-binding-site","display_name":"inhibitor binding site","score":0.6850000023841858},{"id":"https://openalex.org/keywords/leishmania-tarentolae","display_name":"Leishmania tarentolae","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cryo-em-structure","display_name":"cryo-EM structure","score":0.7770000100135803},{"id":"https://openalex.org/keywords/neglected-tropical-diseases","display_name":"neglected tropical diseases","score":0.7160000205039978},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7459999918937683},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.4359999895095825},{"id":"https://openalex.org/keywords/miltefosine","display_name":"miltefosine","score":0.9290000200271606}],"concepts":[{"id":"https://openalex.org/C2778689377","wikidata":"https://www.wikidata.org/wiki/Q2046113","display_name":"Visceral leishmaniasis","level":3,"score":0.7876123189926147},{"id":"https://openalex.org/C2781333301","wikidata":"https://www.wikidata.org/wiki/Q1950752","display_name":"Leishmania donovani","level":4,"score":0.7781600952148438},{"id":"https://openalex.org/C2781257258","wikidata":"https://www.wikidata.org/wiki/Q1950789","display_name":"Leishmania infantum","level":4,"score":0.7601838111877441},{"id":"https://openalex.org/C2781417161","wikidata":"https://www.wikidata.org/wiki/Q411787","display_name":"Miltefosine","level":4,"score":0.6836288571357727},{"id":"https://openalex.org/C2776555147","wikidata":"https://www.wikidata.org/wiki/Q331283","display_name":"Leishmaniasis","level":2,"score":0.6623075008392334},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.5906795859336853},{"id":"https://openalex.org/C2781092759","wikidata":"https://www.wikidata.org/wiki/Q524818","display_name":"Leishmania","level":3,"score":0.5733397006988525},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5401744842529297},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5217610001564026},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47939300537109375},{"id":"https://openalex.org/C2780599195","wikidata":"https://www.wikidata.org/wiki/Q1950715","display_name":"Leishmania major","level":4,"score":0.4209352433681488},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4191136360168457},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.41352778673171997},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3530946373939514},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2551364302635193},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22334513068199158},{"id":"https://openalex.org/C71928629","wikidata":"https://www.wikidata.org/wiki/Q804206","display_name":"Parasite hosting","level":2,"score":0.09452563524246216},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08825996518135071},{"id":"https://openalex.org/C136764020","wikidata":"https://www.wikidata.org/wiki/Q466","display_name":"World Wide Web","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000981","descriptor_name":"Antiprotozoal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000981","descriptor_name":"Antiprotozoal Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007893","descriptor_name":"Leishmania donovani","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007893","descriptor_name":"Leishmania donovani","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D007893","descriptor_name":"Leishmania donovani","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007898","descriptor_name":"Leishmaniasis, Visceral","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D007898","descriptor_name":"Leishmaniasis, Visceral","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015800","descriptor_name":"Protozoan Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015800","descriptor_name":"Protozoan Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015800","descriptor_name":"Protozoan Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018314","descriptor_name":"Leishmania infantum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018314","descriptor_name":"Leishmania infantum","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D018314","descriptor_name":"Leishmania infantum","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D046988","descriptor_name":"Proteasome Endopeptidase Complex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D046988","descriptor_name":"Proteasome Endopeptidase Complex","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1073/pnas.1820175116","doi":"https://doi.org/10.1073/pnas.1820175116","is_oa":true,"landing_page_url":"https://doi.org/10.1073/pnas.1820175116","pdf_url":"https://www.pnas.org/content/pnas/116/19/9318.full.pdf","source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6511062","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6511062","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proc Natl Acad Sci U S A","raw_type":"Text"},{"id":"pmid:30962368","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30962368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences of the United States of America","raw_type":"Journal Article"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire/64a4d105-62ad-4941-9ff9-59a04f31a0ba","doi":null,"is_oa":true,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/64a4d105-62ad-4941-9ff9-59a04f31a0ba","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1073/pnas.1820175116","doi":"https://doi.org/10.1073/pnas.1820175116","is_oa":true,"landing_page_url":"https://doi.org/10.1073/pnas.1820175116","pdf_url":"https://www.pnas.org/content/pnas/116/19/9318.full.pdf","source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G191375389","display_name":"A Translational Engine for Biomedical Discoveries .","funder_award_id":"100476","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G2165916381","display_name":"A pipeline of drugs for leishmaniasis and Chagas' disease.","funder_award_id":"204672/Z/16/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G2241294789","display_name":"High throughput decoding of virulence mechanisms in African trypanosomes.","funder_award_id":"100320/Z/12/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G2798463132","display_name":"Discovery and Development of Drug Candidates for Neglected Diseases.","funder_award_id":"092340","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G3440049782","display_name":"Chemical biology: Leveraging phenotypic hits against kinetoplastids.","funder_award_id":"105021","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G3977893489","display_name":"Chemical biology: Leveraging phenotypic hits against kinetoplastids.","funder_award_id":"105021/Z/14/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G4632695219","display_name":"Protein glycosylation in trypanosomes: defining and exploiting a biological system.","funder_award_id":"101842/Z/13/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G5559287737","display_name":"Centre for Neglected Tropical Diseases Drug Discovery","funder_award_id":"203134/Z/16/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2936802406.pdf","grobid_xml":"https://content.openalex.org/works/W2936802406.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W17045578","https://openalex.org/W1608074466","https://openalex.org/W2000142729","https://openalex.org/W2033995423","https://openalex.org/W2062016511","https://openalex.org/W2097796255","https://openalex.org/W2123082391","https://openalex.org/W2148707789","https://openalex.org/W2150856560","https://openalex.org/W2158168571","https://openalex.org/W2158892689","https://openalex.org/W2160380481","https://openalex.org/W2160728506","https://openalex.org/W2194509219","https://openalex.org/W2321752808","https://openalex.org/W2478575915","https://openalex.org/W2495203971","https://openalex.org/W2519666645","https://openalex.org/W2765434054","https://openalex.org/W2766577344","https://openalex.org/W2884300490","https://openalex.org/W2896442353","https://openalex.org/W4211073781","https://openalex.org/W4230274588"],"related_works":["https://openalex.org/W7221774482","https://openalex.org/W2944934312","https://openalex.org/W2899500618","https://openalex.org/W6889733325","https://openalex.org/W4313429912","https://openalex.org/W3157065829","https://openalex.org/W4317103896","https://openalex.org/W2904094032","https://openalex.org/W2033112004","https://openalex.org/W2031707865"],"abstract_inverted_index":{"Visceral":[0],"leishmaniasis":[1],"(VL),":[2],"caused":[3],"by":[4,69,148,155],"the":[5,17,47,76,85,90,132,151,156,160,185],"protozoan":[6],"parasites":[7,204],"Leishmania":[8,11,172],"donovani":[9,106,162],"and":[10,107,117,169,187,202,205,213,223,229],"infantum":[12,109],",":[13],"is":[14,23,206,234],"one":[15],"of":[16,49,84,92,102,126,131,139,150,159,167,210,219],"major":[18],"parasitic":[19],"diseases":[20],"worldwide.":[21],"There":[22],"an":[24],"urgent":[25],"need":[26],"for":[27,38],"new":[28],"drugs":[29],"to":[30,58,225],"treat":[31,59],"VL,":[32],"because":[33],"current":[34,133],"therapies":[35],"are":[36,198],"unfit":[37],"purpose":[39],"in":[40,89,119,122],"a":[41,50,73,93,100,177,217,226],"resource-poor":[42],"setting.":[43],"Here,":[44],"we":[45],"describe":[46],"development":[48,91],"preclinical":[51],"drug":[52],"candidate,":[53],"GSK3494245/DDD01305143/compound":[54],"8,":[55],"with":[56,97,129,208],"potential":[57],"this":[60,144],"neglected":[61],"tropical":[62],"disease.":[63],"The":[64],"compound":[65,96,145,170,232],"series":[66,87],"was":[67],"discovered":[68],"repurposing":[70],"hits":[71],"from":[72],"screen":[74],"against":[75,99],"related":[77],"parasite":[78],"Trypanosoma":[79],"cruzi":[80],".":[81],"Subsequent":[82],"optimization":[83],"chemical":[86],"resulted":[88],"potent":[94],"cidal":[95],"activity":[98,153],"range":[101],"clinically":[103],"relevant":[104],"L.":[105,108,161],"isolates.":[110],"Compound":[111],"8":[112,233],"demonstrates":[113],"promising":[114],"pharmacokinetic":[115],"properties":[116],"impressive":[118],"vivo":[120],"efficacy":[121],"our":[123,211],"mouse":[124],"model":[125],"infection":[127],"comparable":[128],"those":[130],"oral":[134],"antileishmanial":[135],"miltefosine.":[136],"Detailed":[137],"mode":[138],"action":[140],"studies":[141,222],"confirm":[142],"that":[143,182,197],"acts":[146],"principally":[147],"inhibition":[149],"chymotrypsin-like":[152],"catalyzed":[154],"\u03b25":[157,188],"subunit":[158],"proteasome.":[163],"High-resolution":[164],"cryo-EM":[165],"structures":[166],"apo":[168],"8-bound":[171],"tarentolae":[173],"20S":[174],"proteasome":[175,189],"reveal":[176],"previously":[178],"undiscovered":[179],"inhibitor":[180],"site":[181],"lies":[183],"between":[184,200],"\u03b24":[186,195],"subunits.":[190],"This":[191],"induced":[192],"pocket":[193],"exploits":[194],"residues":[196],"divergent":[199],"humans":[201],"kinetoplastid":[203],"consistent":[207],"all":[209],"experimental":[212],"mutagenesis":[214],"data.":[215],"As":[216],"result":[218],"these":[220],"comprehensive":[221],"due":[224],"favorable":[227],"developability":[228],"safety":[230],"profile,":[231],"being":[235],"advanced":[236],"toward":[237],"human":[238],"clinical":[239],"trials.":[240]},"counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":32},{"year":2023,"cited_by_count":31},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":24},{"year":2020,"cited_by_count":29},{"year":2019,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-04-25T00:00:00"}